About
ENDOless is an AI-powered health platform built specifically for women living with chronic gynecological conditions such as endometriosis, PCOS, PMS, and chronic pelvic pain. It addresses a critical systemic failure in women's healthcare: the absence of longitudinal, objective health data that contributes to diagnostic delays often spanning nearly a decade. At its core, ENDOless is a privacy-first AI companion that enables women to continuously log symptoms, pain patterns, fatigue, and other multi-dimensional health indicators. Unlike traditional period-tracking apps, ENDOless builds a comprehensive, ongoing view of each user's health journey — transforming subjective experiences into structured, clinically meaningful data. The platform operates with a dual mission: empowering individual women to better understand and manage their conditions, while generating the anonymized datasets medical research needs to finally illuminate women's physiology. AI-driven pattern recognition surfaces predictive insights and correlations that help users and their care teams make more informed decisions. Selected for the HIIT health innovation accelerator in France and featured in the 2026 Mapping of French AI Startups by France Digitale, ENDOless is gaining recognition in the digital health ecosystem. It offers tiered membership options and is currently in early access beta ahead of its full public launch. The platform is built for women seeking better advocacy tools, as well as for healthcare providers and researchers seeking deeper insights into underdiagnosed chronic conditions.
Key Features
- Longitudinal AI Symptom Tracking: Continuously logs pain levels, fatigue, and multi-dimensional symptoms over time, replacing fragmented snapshots with a comprehensive, evolving health timeline.
- Predictive Health Insights: AI analyzes recorded patterns to surface predictive insights, helping women anticipate symptom flares and better understand their cyclical health dynamics.
- Medical-Grade Privacy: Built with a privacy-first architecture ensuring sensitive personal health data is secured and handled in compliance with medical data protection standards.
- Research-Grade Data Generation: Aggregates anonymized, structured symptom data that contributes to broader medical research on women's chronic conditions — turning individual experiences into scientific evidence.
- Multi-Condition Coverage: Supports endometriosis, PCOS, PMS, and chronic pelvic pain within a single unified platform, recognizing the overlap and shared blind spots across these conditions.
Use Cases
- A woman with endometriosis uses ENDOless to track daily pain, fatigue, and symptom patterns, generating objective data to share with her gynecologist and reduce diagnostic delays.
- A PCOS patient logs hormonal symptoms and lifestyle factors over several months, using AI insights to identify personal triggers and correlations.
- A medical researcher partners with ENDOless to access anonymized, research-grade population-level data on chronic pelvic pain patterns.
- A woman experiencing unexplained pelvic pain documents her full symptom history with ENDOless, building a structured record to support faster clinical evaluation.
- A digital health organization integrates ENDOless into its ecosystem to offer more comprehensive women's health tracking and improve clinical protocol development.
Pros
- Addresses a Critical Unmet Need: Specifically designed for chronically underdiagnosed women's health conditions, filling a gap that general-purpose health apps and period trackers fail to address.
- Longitudinal Data Approach: Builds a continuous health record rather than periodic snapshots, enabling far more meaningful insights and objective evidence for medical appointments.
- Dual Personal and Research Impact: Simultaneously empowers individual users and contributes to medical research, creating personal value while advancing systemic understanding of women's health.
- Recognized by Health Innovation Programs: Selected for the HIIT accelerator and featured by France Digitale, lending credibility to the platform's medical and technological approach.
Cons
- Not Yet Publicly Available: The platform is still in early access beta as of 2026, meaning most users must join a waitlist and full features are not yet accessible to the general public.
- Narrow Target Audience: Focused exclusively on women's chronic gynecological conditions, making it irrelevant for users with broader or different health tracking needs.
- Early-Stage Product Uncertainty: As a startup still in an accelerator program, long-term feature stability, clinical validation depth, and support availability are yet to be fully established.
Frequently Asked Questions
When will ENDOless be available to the public?
ENDOless is currently in beta and plans a full public launch in Q1 2026. You can join the waitlist to get early access and help shape the product before its official release.
How is ENDOless different from other period tracking apps?
ENDOless goes far beyond basic period tracking by focusing on chronic gynecological conditions with continuous, longitudinal symptom tracking and AI-driven predictive insights — rather than simple cycle monitoring.
What conditions does ENDOless support?
ENDOless supports tracking for endometriosis, PCOS, PMS, and chronic pelvic pain, with plans to expand to other women's health conditions that share similar systemic blind spots in current healthcare.
How does ENDOless protect my sensitive health data?
ENDOless is built with medical-grade privacy standards at its core, ensuring that personal health data is stored securely and handled in compliance with healthcare data protection regulations.
Can ENDOless help me get a faster diagnosis?
While ENDOless is not a diagnostic tool, it helps you build an objective, longitudinal record of your symptoms that you can share with healthcare providers — reducing reliance on memory and supporting faster, more informed clinical conversations.
